- Home
- CMPS vs PACB Comparison
CMPS vs PACB Comparison
Compare CMPS & PACB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CMPS
- PACB
- Stock Information
- Founded
- CMPS 2020
- PACB 2000
- Country
- CMPS United Kingdom
- PACB United States
- Employees
- CMPS N/A
- PACB N/A
- Industry
- CMPS Biotechnology: Pharmaceutical Preparations
- PACB Biotechnology: Laboratory Analytical Instruments
- Sector
- CMPS Health Care
- PACB Industrials
- Exchange
- CMPS Nasdaq
- PACB Nasdaq
- Market Cap
- CMPS 364.9M
- PACB 364.2M
- IPO Year
- CMPS 2020
- PACB 2010
- Fundamental
- Price
- CMPS $2.73
- PACB $1.19
- Analyst Decision
- CMPS Strong Buy
- PACB Buy
- Analyst Count
- CMPS 7
- PACB 8
- Target Price
- CMPS $17.83
- PACB $2.13
- AVG Volume (30 Days)
- CMPS 3.9M
- PACB 10.1M
- Earning Date
- CMPS 07-31-2025
- PACB 08-06-2025
- Dividend Yield
- CMPS N/A
- PACB N/A
- EPS Growth
- CMPS N/A
- PACB N/A
- EPS
- CMPS N/A
- PACB N/A
- Revenue
- CMPS N/A
- PACB $152,357,000.00
- Revenue This Year
- CMPS N/A
- PACB $3.33
- Revenue Next Year
- CMPS N/A
- PACB $18.52
- P/E Ratio
- CMPS N/A
- PACB N/A
- Revenue Growth
- CMPS N/A
- PACB N/A
- 52 Week Low
- CMPS $2.25
- PACB $0.85
- 52 Week High
- CMPS $8.54
- PACB $2.72
- Technical
- Relative Strength Index (RSI)
- CMPS 29.61
- PACB 51.50
- Support Level
- CMPS $2.25
- PACB $1.16
- Resistance Level
- CMPS $5.15
- PACB $1.40
- Average True Range (ATR)
- CMPS 0.40
- PACB 0.10
- MACD
- CMPS -0.27
- PACB 0.01
- Stochastic Oscillator
- CMPS 9.83
- PACB 46.49
About CMPS COMPASS Pathways Plc American Depository Shares
Compass Pathways PLC is a mental health care company dedicated to accelerating patient access to evidence-based innovation in mental health. The company is motivated by the need to find ways to help and empower people suffering with mental health challenges who are not helped by existing therapies and are pioneering the development of a new model of psilocybin therapy, in which psilocybin is administered in conjunction with psychological support. Its focus is on treatment-resistant depression, or TRD, a subset of major depressive disorder, or MDD, comprising patients who are inadequately served by the treatment paradigm. It has developed a proprietary, high-purity polymorphic crystalline formulation of psilocybin, COMP360.
About PACB Pacific Biosciences of California Inc.
Pacific Biosciences of California Inc is a biotechnology company focused on designing, developing, and manufacturing sequencing solutions that enable scientists and clinical researchers to improve their understanding of the genome and ultimately, resolve genetically complex problems. It operates in, one reportable segment: the development, manufacturing, and marketing of an integrated platform for genetic analysis. The majority of the company's revenue is derived from Americas, followed by Asia-Pacific and Europe Middle East, and Africa.